Determinants of survival in sinonasal and skull base chondrosarcoma: An analysis of the National Cancer Database.

Ryan A RimmerJess C MacePeter E AndersenJustin S CetasJeremy N CiporenAclan DoganTimothy L SmithMathew Geltzeiler

Published in: International forum of allergy & rhinology (2021)

Sinonasal and skull base chondrosarcoma are primarily treated with surgery with favorable OS. Adjuvant treatment may be required and proton radiation was associated with improved 60-month and 120-month survival compared with conventional radiation.

Keyphrases

minimally invasive
free survival
early stage
radiation induced
combination therapy
adverse drug
acute coronary syndrome
newly diagnosed
electronic health record
drug induced